AMTAGVI

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 73776-001
  • Package NDC 73776-001-12
  • Application number BLA125773
  • SPL ID 4120d6b2-93d7-e0bf-e063-6294a90a6e7f
  • SPL set ID 4121bd3f-2d6e-3bdd-e063-6294a90a3088
  • UNII R0835E18NH
  • RxCUI 2675868
  • RxCUI 2675874

What the source publishes

Labeler
Iovance Biotherapeutics Inc.
Active ingredients
lifileucel
Form
SUSPENSION
Routes
INTRAVENOUS
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
CELLULAR THERAPY

Names this record is found by

Complete source data
us:fda:ndc:73776-001_4120d6b2-93d7-e0bf-e063-6294a90a6e7f
{
  "name": "AMTAGVI",
  "splId": "4120d6b2-93d7-e0bf-e063-6294a90a6e7f",
  "labels": [
    {
      "setId": "4121bd3f-2d6e-3bdd-e063-6294a90a3088",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4121bd3f-2d6e-3bdd-e063-6294a90a3088",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4121bd3f-2d6e-3bdd-e063-6294a90a3088"
    }
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "labeler": "Iovance Biotherapeutics Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 BAG in 1 CARTRIDGE (73776-001-12)  / 125 mL in 1 BAG (73776-001-11)",
      "package_ndc": "73776-001-12",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20240216"
    }
  ],
  "productId": "73776-001_4120d6b2-93d7-e0bf-e063-6294a90a6e7f",
  "useDomain": "unknown",
  "dosageForm": "SUSPENSION",
  "productNdc": "73776-001",
  "deaSchedule": null,
  "genericName": "lifileucel",
  "productType": "CELLULAR THERAPY",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "LIFILEUCEL",
      "strength": "72000000000 1/500mL"
    }
  ],
  "applicationNumber": "BLA125773",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20240216",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "unknown",
  "harmonizedIdentifiers": {
    "upc": [
      "0373776001121"
    ],
    "unii": [
      "R0835E18NH"
    ],
    "rxcui": [
      "2675868",
      "2675874"
    ],
    "spl_set_id": [
      "4121bd3f-2d6e-3bdd-e063-6294a90a3088"
    ],
    "manufacturer_name": [
      "Iovance Biotherapeutics Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:73776-001_4120d6b2-93d7-e0bf-e063-6294a90a6e7f"